Does anybody knowwhat happened with the agreement Zelira entered into in December 2018 with Suda Pharmaceuticals to develop an oral spray formulation to deliver the company’s cannabis medicines?
The term of that agreement was to last 24 months - which would bring us to the end of 2020. Are we right to assume therefore now that that deadline has come and gone that the agreement has been terminated and will not be progressed any further?
Add to My Watchlist
What is My Watchlist?
